207 related articles for article (PubMed ID: 17854873)
1. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
Zhao C; Austin RM
Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
3. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
[TBL] [Abstract][Full Text] [Related]
4. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
5. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
Bansal M; Austin RM; Zhao C
Gynecol Oncol; 2009 Nov; 115(2):257-61. PubMed ID: 19665217
[TBL] [Abstract][Full Text] [Related]
6. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
7. Molecular testing of human papillomavirus in cervical specimens.
Gazzaz FB
Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
[TBL] [Abstract][Full Text] [Related]
8. The significance of high-risk human papillomavirus detection in women aged > or = 50 years with atypical squamous cells of undetermined significance cytologic preparations.
Rosario D; Zahn CM; Bush AC; Kendall BS
Cancer; 2007 Dec; 111(6):487-90. PubMed ID: 17973252
[TBL] [Abstract][Full Text] [Related]
9. An analysis of human papillomavirus testing and endocervical component on pap tests: A pilot study using the Roche Cobas(®) assay.
Pierce KJ; Currens HS; Tafe LJ; Tsongalis GJ; Padmanabhan V
Diagn Cytopathol; 2016 Apr; 44(4):280-2. PubMed ID: 26801205
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
Schiffman M; Wheeler CM; Castle PE;
J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.
Gao FF; Austin RM; Zhao C
Cancer Cytopathol; 2011 Dec; 119(6):377-86. PubMed ID: 21774093
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
[TBL] [Abstract][Full Text] [Related]
15. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
16. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
17. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
[TBL] [Abstract][Full Text] [Related]
19. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
20. Anal human papillomavirus testing with Digene's hybrid capture 2 using two different sampling methods.
Roka F; Roka J; Trost A; Schalk H; Zagler C; Kirnbauer R; Salat A
Dis Colon Rectum; 2008 Jan; 51(1):62-6. PubMed ID: 18030530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
